Evidence map›Paper›PMID 33264359›Full record

ArticlePloS one2020

Reperfused hemorrhagic myocardial infarction in rats.

Anand R Nair, Eric A Johnson, Hsin-Jung Yang, Ivan Cokic, Joseph Francis, Rohan Dharmakumar

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in PloS one, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05604131 (Cardiac MRI-guided Deferiprone Therapy for Acute Myocardial Infarction Patients), which is not on this map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05604131 phase2recruitingnot on this mapstarted 2022, after this paper: background citation

Cardiac MRI-guided Deferiprone Therapy for Acute Myocardial Infarction Patients

TypeinterventionalSponsorRohan DharmakumarRan2022 to 2029Enrolled89ConditionsAcute Myocardial Infarction Type 1ArmsDeferiprone Tablets, Placebo
3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Anand R NairCedars-Sinai Medical Center, Department of Biomedical Sciences, Biomedical Imaging Research Institute, Los Angeles, CA, United States of America.
Eric A JohnsonCedars-Sinai Medical Center, Department of Biomedical Sciences, Biomedical Imaging Research Institute, Los Angeles, CA, United States of America.
Hsin-Jung YangCedars-Sinai Medical Center, Department of Biomedical Sciences, Biomedical Imaging Research Institute, Los Angeles, CA, United States of America.ORCID 0000-0002-5576-9568
Ivan CokicCedars-Sinai Medical Center, Department of Biomedical Sciences, Biomedical Imaging Research Institute, Los Angeles, CA, United States of America.
Joseph FrancisDepartment of Comparative Biomedical Sciences, School of Veterinary Medicine, Louisiana State University, Baton Rouge, LA, United States of America.
Rohan DharmakumarCedars-Sinai Medical Center, Department of Biomedical Sciences, Biomedical Imaging Research Institute, Los Angeles, CA, United States of America.ORCID 0000-0003-4120-4635
Cedars-Sinai Medical Center · USLouisiana State University · US

Funding

Mechanistic Insights to A Translatable Therapy for Acute Reperfused Hemorrhagic Myocardial InfarctionsR01HL147133 · NHLBI · INDIANA UNIVERSITY INDIANAPOLIS · PI DHARMAKUMAR, ROHAN, FRANCIS, JOSEPH · 2020 to 2023
$3.2M
NHLBI NIH HHS R01 HL147133
6 · The paper itself

Abstract

backgroundIntramyocardial hemorrhage following reperfusion is strongly associated with major adverse cardiovascular events in myocardial infarction (MI) patients; yet the mechanisms contributing to these outcomes are not well understood. Large animal models have been used to investigate intramyocardial hemorrhage, but they are exorbitantly expensive and difficult to use for mechanistic studies. In contrast, rat models are widely used to investigate mechanistic aspects of cardiovascular physiology, but a rat model that consistently recapitulates the characteristics of an hemorrhagic MI does not exist. To bridge this gap, we investigated the physiological conditions of MI that would create intramyocardial hemorrhage in rats so that a reliable model of hemorrhagic MI would become available for basic research. METHODS &

resultsSprague-Dawley rats underwent either a 90-minute (90-min) ischemia and then reperfusion (I/R) (n = 22) or 30-minute (30-min) I/R (n = 18) of the left anterior descending coronary artery. Sham rats (n = 12) were used as controls. 90-min I/R consistently yielded hemorrhagic MI, while 30-min I/R consistently yielded non-hemorrhagic MI. Twenty-four hours post-reperfusion, ex-vivo late-gadolinium-enhancement (LGE) and T2* cardiac MRI performed on excised hearts from 90-min I/R rats revealed colocalization of iron deposits within the scarred tissue; however, in 30-min I/R rats scar was evident on LGE but no evidence of iron was found on T2* CMR. Histological studies verified tissue damage (H&E) detected on LGE and the presence of iron (Perl's stain) observed on T2*-CMR. At week 4 post-reperfusion, gene and protein expression of proinflammatory markers (TNF-α, IL-1β and MMP-9) were increased in the 90-min I/R group when compared to 30-min I/R groups. Further, transmission electron microscopy performed on 90-min I/R myocardium that were positive for iron on T2* CMR and Perl's stain showed accumulation of granular iron particles within the phagosomes.

conclusionIschemic time prior to reperfusion is a critical factor in determining whether a MI is hemorrhagic or non-hemorrhagic in rats. Specifically, a period of 90-min of ischemia prior to reperfusion can produce rat models of hemorrhagic MI, while 30-minutes of ischemia prior to reperfusion can ensure that the MIs are non-hemorrhagic. Hemorrhagic MIs in rats result in marked increase in iron deposition, proinflammatory burden and adverse left-ventricular remodeling compared to rats with non-hemorrhagic MIs.

Indexed as

AnimalsBiomarkersDisease Models, AnimalGadoliniumHemorrhageInterleukin-1betaMagnetic Resonance Imaging, CineMaleMatrix Metalloproteinase 9Myocardial InfarctionMyocardial Reperfusion InjuryRatsRats, Sprague-DawleyTime FactorsTumor Necrosis Factor-alphaUp-RegulationBiomarkersGadoliniumIL1B protein, ratInterleukin-1betaMatrix Metalloproteinase 9Mmp9 protein, ratTumor Necrosis Factor-alpha

Identifiers

PMID33264359
PMCPMC7710030
OpenAlexW3107871343

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.